Tenet Healthcare (THC) is highlighted as a top value stock, receiving a Zacks #2 (Buy) Rank and an 'A' grade for both its Value and overall VGM Style Scores. This strong rating is underpinned by a forward P/E of 12.84, recent upward revisions in fiscal 2025 earnings estimates to $15.85 per share (a $0.93 increase), and a historical average earnings surprise of +31.2%, positioning it as a high-probability outperformer according to Zacks' methodology.
Tenet Healthcare (THC) is presented with a strong bullish case, primarily driven by quantitative metrics from the Zacks ranking system. The company holds a Zacks #2 (Buy) Rank, complemented by an 'A' grade for both its overall VGM (Value, Growth, Momentum) score and its specific Value Style Score. This valuation appeal is substantiated by a forward P/E ratio of 12.84. The positive outlook is further reinforced by upward earnings estimate revisions; two analysts have raised their forecasts for fiscal 2025 within the last 60 days, causing the Zacks Consensus Estimate to increase by $0.93 to $15.85 per share. This forward-looking optimism is supported by a strong historical performance, as THC has demonstrated an average positive earnings surprise of 31.2%, indicating a consistent ability to exceed market expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment